Enlaza Therapeutics’ $100 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction.Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here